- Survival of Older Patients With Cancer in the Veterans Health Administration Versus Fee-for-Service Medicare
[作者:Landrum, MB; Keating, NL; Lamont, EB; Bozeman, SR; Krasnow, SH; Shulman, L; Brown, JR; Earle, CC; Rabin, M; McNeil, BJ,期刊:Journal of clinical oncology, 页码:1072-1079 , 文章类型: Article,,卷期:2012年30-10]
- Purpose The Veterans Health Administration (VHA) provides high-quality preventive chronic care and cancer care, but few studies have documented improved patient outcomes that result from this high-quality care. We compar...
- Polyclonal Immunoglobulin Free Light Chain Levels Predict Survival in Myeloid Neoplasms
[作者:Pardanani, A; Lasho, TL; Finke, CM; Rajkumar, SV; Singh, PP; Ketterling, RP; Hanson, CA; Katzmann, JA; Tefferi, A,期刊:Journal of clinical oncology, 页码:1087-1094 , 文章类型: Article,,卷期:2012年30-10]
- Purpose We hypothesized that surrogate markers of host immune response may predict survival in myeloid malignancies. Because of immediate practical applicability, we chose plasma immunoglobulin free light chain (FLC) con...
- Vandetanib Versus Placebo in Patients With Advanced Non-Small-Cell Lung Cancer After Prior Therapy With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor: A Randomized, Double-Blind Phase III Trial (ZEPHYR)
[作者:Lee, JS; Hirsh, V; Park, K; Qin, SK; Blajman, CR; Perng, RP; Chen, YM; Emerson, L; Langmuir, P; Manegold, C,期刊:Journal of clinical oncology, 页码:1114-1121 , 文章类型: Article,,卷期:2012年30-10]
- Purpose Vandetanib is a once-daily oral inhibitor of vascular endothelial growth factor receptor, epidermal growth factor receptor (EGFR), and RET signaling. This placebo-controlled trial assessed whether vandetanib conf...
- Randomized Phase III Study Comparing Paclitaxel/Cisplatin/Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987
[作者:Bellmunt, J; von der Maase, H; Mead, GM; Skoneczna, I; De Santis, M; Daugaard, G; Boehle, A; Chevreau, C; Paz-Ares, L; Laufman, LR; Winquist, E; Raghavan, D; Marreaud, S; Collette, S; Sylvester, R; de Wit, R,期刊:Journal of clinical oncology, 页码:1107-1113 , 文章类型: Article,,卷期:2012年30-10]
- Purpose The combination of gemcitabine plus cisplatin (GC) is a standard regimen in patients with locally advanced or metastatic urothelial cancer. A phase I/II study suggested that a three-drug regimen that included pac...
- Reflex Immunohistochemistry and Microsatellite Instability Testing of Colorectal Tumors for Lynch Syndrome Among US Cancer Programs and Follow-Up of Abnormal Results
[作者:Beamer, LC; Grant, ML; Espenschied, CR; Blazer, KR; Hampel, HL; Weitzel, JN; MacDonald, DJ,期刊:Journal of clinical oncology, 页码:1058-1063 , 文章类型: Article,,卷期:2012年30-10]
- Purpose Immunohistochemistry (IHC) for MLH1, MSH2, MSH6, and PMS2 protein expression and microsatellite instability (MSI) are well-established tools to screen for Lynch syndrome (LS). Although many cancer centers have ad...
- Carboplatin-Associated Ototoxicity in Children With Retinoblastoma
[作者:Qaddoumi, I; Bass, JK; Wu, JR; Billups, CA; Wozniak, AW; Merchant, TE; Haik, BG; Wilson, MW; Rodriguez-Galindo, C,期刊:Journal of clinical oncology, 页码:1034-1041 , 文章类型: Article,,卷期:2012年30-10]
- Purpose Carboplatin-induced ototoxicity remains poorly defined but is of potential great consequence in children with retinoblastoma. We retrospectively assessed the incidence of ototoxicity and its risk factors in child...
- Cardiovascular Status of Childhood Cancer Survivors Exposed and Unexposed to Cardiotoxic Therapy
[作者:Lipshultz, SE; Landy, DC; Lopez-Mitnik, G; Lipsitz, SR; Hinkle, AS; Constine, LS; French, CA; Rovitelli, AM; Proukou, C; Adams, MJ; Miller, TL,期刊:Journal of clinical oncology, 页码:1050-1057 , 文章类型: Article,,卷期:2012年30-10]
- Purpose To determine whether cardiovascular abnormalities in childhood cancer survivors are restricted to patients exposed to cardiotoxic anthracyclines and cardiac irradiation and how risk factors for atherosclerotic di...
- Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
[作者:Lipshultz, SE; Miller, TL; Scully, RE; Lipsitz, SR; Rifai, N; Silverman, LB; Colan, SD; Neuberg, DS; Dahlberg, SE; Henkel, JM; Asselin, BL; Athale, UH; Clavell, LA; Laverdiere, C; Michon, B; Schorin, MA; Sallan, SE,期刊:Journal of clinical oncology, 页码:1042-1049 , 文章类型: Article; Proceedings Paper,,卷期:2012年30-10]
- Purpose Doxorubicin causes cardiac injury and cardiomyopathy in children with acute lymphoblastic leukemia (ALL). Measuring biomarkers during therapy might help individualize treatment by immediately identifying cardiac ...
|